Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124564932 | 12456493 | 2 | F | 2000 | 20160711 | 20160610 | 20160719 | PER | US-PFIZER INC-2016266636 | PFIZER | 47.00 | YR | M | Y | 0.00000 | 20160719 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124564932 | 12456493 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | 800 MG, UNK (^800MG X 3^) | N | 20235 | 800 | MG | ||||||||
| 124564932 | 12456493 | 2 | SS | NEURONTIN | GABAPENTIN | 1 | N | 20235 | |||||||||||
| 124564932 | 12456493 | 3 | SS | NEURONTIN | GABAPENTIN | 1 | N | 20235 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124564932 | 12456493 | 1 | Burning sensation |
| 124564932 | 12456493 | 2 | Neuropathy peripheral |
| 124564932 | 12456493 | 3 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124564932 | 12456493 | HO |
| 124564932 | 12456493 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124564932 | 12456493 | Drug ineffective for unapproved indication |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124564932 | 12456493 | 1 | 2000 | 0 |